Who Owns Monsanto Corporation: A Shift in Agri Business

The Monsanto Corporation has undergone significant changes in ownership over the years. Bayer, a German multinational pharmaceutical and life sciences company, acquired Monsanto in 2018 for $63 billion.

This acquisition marked a major shift in the agri-business industry, with Bayer becoming the largest seeds and pesticides company in the world. The deal was finalized on June 7, 2018.

The acquisition was a strategic move by Bayer to expand its presence in the agricultural sector. Monsanto's portfolio of seeds and pesticides was a key factor in the deal.

Recommended read: A Company That Owns a Life Insurance Policy

Bayer successfully completed the acquisition of Monsanto on June 7, 2018. The U.S. company's shares will no longer be traded on the New York Stock Exchange, with Bayer now the sole owner of Monsanto Company.

Monsanto shareholders received $128 per share as part of the deal. J.P. Morgan assisted Bayer with processing the purchase price payment for the largest acquisition in the company’s history.

See what others are reading: Who Owns Target Corp

Liam Condon, a member of the Bayer Board of Management, will lead the combined Crop Science Division when the integration commences. Until that time, Monsanto will operate independently from Bayer.

The combined company will be known simply as Bayer, while product names will remain the same. This move is likely due to the negative associations associated with the Monsanto brand.

Werner Baumann, Chairman of the Bayer Board of Management, stated that the acquisition has the potential to create significant value for shareholders. He also emphasized the importance of sustainability and living up to the heightened responsibility that comes with a leadership position in agriculture.

The integration process is expected to commence in approximately two months, after the divestments to BASF have been completed. This was a condition of the conditional approval from the United States Department of Justice.

You might like: Monsanto Stock Symbol

Bayer successfully completed the acquisition of Monsanto on June 7, 2018, making it the sole owner of the US company.

Shares in Monsanto will no longer be traded on the New York Stock Exchange, and shareholders are being paid $128 per share.

The integration of Monsanto into Bayer can take place as soon as the divestments to BASF have been completed, which is expected to happen in approximately two months.

Werner Baumann, Chairman of the Bayer Board of Management, described the acquisition as a great day for customers, shareholders, and society.

The combined company aims to help farmers grow more healthy and affordable food in a sustainable manner.

Monsanto's CEO, Hugh Grant, stated that the closing represents an important milestone toward creating a leading agricultural company.

The acquisition has the potential to create significant value for shareholders.

Liam Condon, a member of the Bayer Board of Management, will lead the combined Crop Science Division when the integration commences.

You might like: Parent Company

Monsanto is on the verge of becoming part of a massive merger with Bayer, one of the world's largest pesticide producers.

The combined company will be the world's largest seed and ag-chemical company, a title that's been a long time coming for Monsanto.

This merger is a significant development in the industry, marking a shift from small-town firms to global giants.

Monsanto's history is marked by its evolution from a small-town firm to a global player.

The merger with Bayer will be completed on June 7, bringing together two industry leaders.

By any name, the new company will be a behemoth in the industry, with a presence that's hard to ignore.

Bayer successfully completed the acquisition of Monsanto on June 7, 2018.

The acquisition was the largest in Bayer's history, with J.P. Morgan assisting with the purchase price payment.

Shares in Monsanto will no longer be traded on the New York Stock Exchange, with Bayer now the sole owner of Monsanto Company.

Monsanto shareholders were paid $128 per share as part of the deal.

The integration of Monsanto into Bayer can take place as soon as the divestments to BASF have been completed, which is expected to happen in approximately two months.

Liam Condon, a member of the Bayer Board of Management, will lead the combined Crop Science Division when the integration commences.

Monsanto will operate independently from Bayer until then.

The combined company will be known as Bayer, with product names remaining the same.

The move to drop the Monsanto name was likely due to the intense negative associations associated with the brand.

Bayer aims to deepen its dialogue with society and listen to its critics, working together where possible.

The acquisition has made Bayer the leading seller of GMOs in Europe, a move that may have significant implications.

The deal was conditional on the divestment of $9 billion in agricultural assets, which Bayer will sell to BASF.

Each Monsanto shareholder received $128 per share as part of the deal.

Bayer's Chairman of the Board of Management, Werner Baumann, described the acquisition as a great day for customers, shareholders, and consumers.

The acquisition represents an important milestone toward creating a leading agricultural company, supporting growers in their efforts to be more productive and sustainable.

The combined company aims to help the world's farmers grow more healthy and affordable food in a sustainable manner.

Liam Condon, president of Bayer's Crop Science Division, admits that the purchase took at least a year longer than anticipated.

The "hold separate" required by the Department of Justice meant intimate business details couldn't be shared prior to the formal close.

Brett Begemann, a 35-year Monsanto veteran and the new chief operating officer at Bayer Crop Science, acknowledges that farmers are already thinking about 2019 seed purchases.

Farmers shouldn't expect to see significant changes in seed catalogs, as the crop-protection side of the business for the coming year will be mostly based on Bayer's offerings.

Begemann projects that data and data analytics will change agriculture more in the future than biotechnology changed agriculture.